Leerink Sees Limited Near-Term Upside for Zimmer Biomet Holdings, Inc. (ZBH) Ahead of 2027 Catalysts
TheFly reported on April 13 that Leerink Partners began coverage of ZBH with a Market Perform rating and a $10 price target.
Zimmer Biomet Holdings Inc. (ZBH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $104.75 | 2,135 | $223,641.25 | 4,060 | 2023-11-09 | Filing | |
| $117.11 | 1,000 | $117,114.00 | 3,540 | 2023-08-28 | Filing | |
| $120.37 | 1,000 | $120,370.00 | 1,000 | 2023-08-30 | Filing | |
| $116.48 | 2,000 | $232,960.00 | 4,000 | 2023-08-28 | Filing | |
| $115.50 | 1,300 | $150,150.00 | 3,385 | 2023-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $94.66 | 2,650 | $250,849.00 | 10,224 | 2026-03-12 | Filing | |
| $96.49 | 1,000 | $96,490.00 | 17,670 | 2026-02-12 | Filing | |
| $103.59 | 1,200 | $124,302.00 | 18,584 | 2025-09-11 | Filing | |
| $104.15 | 1,500 | $156,225.00 | 6,833 | 2025-09-08 | Filing | |
| $102.49 | 1,500 | $153,735.00 | 8,333 | 2025-08-18 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 475,090 | $42,957,678 | 0.62% | |
| 2. | 176,364 | $15,946,833 | 0.63% | |
| 3. | 154,375 | $13,652,153 | 6.69% | |
| 4. | 135,663 | $12,266,648 | 1.08% | |
| 5. | 94,088 | $8,507,403 | 0.42% |
News See All
10 Best Healthcare Stocks to Buy and Hold for 3 Years
The first quarter of this year has seen a great deal of volatility in the equity markets. The S&P 500 fell into correction territory before rising again after first soaring to all-time highs.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q4 2025 Earnings Call Transcript
Operator: Please stand by. Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2025 Earnings Conference Call.
Zimmer Biomet Holdings (ZBH)'s 2026 Expectations Remain Cautious Amid Internal Reset
On January 13, 2026, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) laid out cautious expectations for 2026 at the 44th Annual J.P. Morgan Healthcare Conference, according to The Fly.
10 Undervalued Wide Moat Stocks to Buy Right Now
As U.S. markets go further into 2026, they are witnessing a shift in the macro backdrop that is reshaping expectations across asset classes. Following a sluggish 2025, U.S.
Zimmer Biomet (ZBH) Gives Up 15% on Weak Q3
Zimmer dropped its share prices by 15.15 percent on Wednesday to end at $87.55 apiece as investors soured on its organic sales growth forecast amid weakness in international markets, alongside a weak ...
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2025 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2025 Earnings Call Transcript November 5, 2025Zimmer Biomet Holdings, Inc. misses on earnings expectations.
Zimmer Biomet (ZBH) Acquires Monogram Technologies to Expand AI-Driven Orthopedic Robotics Portfolio
Zimmer Biomet Holdings Inc. (NYSE:ZBH) ranks among the best medical device stocks to invest in. Zimmer Biomet Holdings Inc.
12 Best Medical Device Stocks to Invest In Now
As chronic diseases like diabetes and cancer become more common, medical device technology is becoming increasingly innovative.
Do You Believe in the Upside Potential of Zimmer Biomet Holdings (ZBH)?
Ariel Investments, an investment management company, released its “Ariel Global Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center